GLP-1 drugs like Ozempic may lower the risk of addiction: new study
- Written by Shalini Arunogiri, Addiction Psychiatrist, Associate Professor, Monash University
Alvaro Golzalez/Getty ImagesA class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows.
Semaglutide (also known as Ozempic), liraglutide and tirzepatide (Wegovy) belong to a class of drugs called GLP-1 (glucagon-like peptide-1) receptor...





